A detailed history of Financial Gravity Asset Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 23,509 shares of NVO stock, worth $3.26 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
23,509
Previous 23,511 0.01%
Holding current value
$3.26 Million
Previous $2.43 Billion 0.05%
% of portfolio
0.68%
Previous 0.68%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 26, 2024

SELL
$102.11 - $135.92 $204 - $271
-2 Reduced 0.01%
23,509 $2.43 Billion
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $23.7 Million - $31.5 Million
-231,819 Reduced 90.91%
23,177 $2.98 Billion
Q4 2023

Jun 26, 2024

BUY
$87.78 - $105.45 $29,318 - $35,220
334 Added 1.44%
23,511 $2.43 Billion
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $22.4 Million - $49.2 Million
246,334 Added 2843.85%
254,996 $23.2 Million
Q2 2023

Aug 08, 2023

SELL
$155.98 - $172.65 $40,710 - $45,061
-261 Reduced 2.93%
8,662 $2.2 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $794,437 - $955,317
6,003 Added 205.58%
8,923 $5.75 Million
Q4 2022

Feb 15, 2023

SELL
$102.55 - $135.33 $39,379 - $51,966
-384 Reduced 11.62%
2,920 $1.32 Million
Q3 2022

Nov 03, 2022

SELL
$95.28 - $116.93 $550,242 - $675,270
-5,775 Reduced 63.61%
3,304 $285,000
Q2 2022

Aug 05, 2022

BUY
$103.24 - $121.81 $560,283 - $661,062
5,427 Added 148.6%
9,079 $935,000
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $382,082 - $461,864
-4,104 Reduced 52.91%
3,652 $339,000
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $102,591 - $125,275
1,070 Added 16.0%
7,756 $680,000
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $707,101 - $893,049
-8,376 Reduced 55.61%
6,686 $731,000
Q2 2021

Aug 11, 2021

BUY
$67.66 - $84.76 $95,874 - $120,104
1,417 Added 10.38%
15,062 $1.35 Million
Q1 2021

May 17, 2021

BUY
$67.06 - $75.82 $403,231 - $455,905
6,013 Added 78.79%
13,645 $935,000
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $487,608 - $563,241
7,632 New
7,632 $533,000
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $116,260 - $134,928
-1,986 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$49.46 - $64.78 $93,083 - $121,915
1,882 Added 1809.62%
1,986 $119,000
Q4 2019

Feb 28, 2020

BUY
$49.86 - $58.26 $797 - $932
16 Added 18.18%
104 $58,000
Q3 2019

Oct 15, 2019

SELL
$47.54 - $53.43 $1,140 - $1,282
-24 Reduced 21.43%
88 $5,000
Q2 2019

Jul 26, 2019

SELL
$46.79 - $52.47 $3,977 - $4,459
-85 Reduced 43.15%
112 $6,000
Q1 2019

Apr 19, 2019

BUY
$46.36 - $52.63 $4,311 - $4,894
93 Added 89.42%
197 $10,000
Q3 2018

Oct 31, 2018

SELL
$46.76 - $51.24 $327 - $358
-7 Reduced 6.31%
104 $4,000
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $354 - $403
-8 Reduced 6.72%
111 $5,000
Q1 2018

May 23, 2018

BUY
$48.49 - $58.14 $5,770 - $6,918
119 New
119 $6,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $313B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.